FORM 8-K |
SURFACE ONCOLOGY, INC. |
(Exact name of Registrant as Specified in Its Charter) |
Delaware
(State or Other Jurisdiction
of Incorporation) |
001-38459
(Commission
File Number) |
46-5543980
(IRS Employer
Identification No.) |
50 Hampshire Street, 8th Floor
Cambridge,MA
(Address of principal executive offices) |
02139
(zip code) |
Registrant's telephone number, including area code:(617)714-4096 |
☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Title of each class | Trading Symbol(s) | Name of exchange on which registered |
Common stock, $0.0001 | SURF | The Nasdaq Global Market |
Exhibit Number | Description |
99.1 |
Surface Oncology, Inc. | ||
Date: March 9, 2023 | By: | /s/ Jessica Fees |
Jessica Fees | ||
Chief Financial Officer | ||
(Principal Financial and Accounting Officer) |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Surface Oncology Inc. published this content on 09 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 09 March 2023 12:04:06 UTC.